Issued 2026-09-16 at $78.46 · now $78.46 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, CBT has typically landed between $69.29 and $89.17 — a range of −11.7% to +13.7% from the issuance price $78.46.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($78.46) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where CBT has typically landed a month from the 2026-09-16 close of $78.46 — the range is history, not a prediction.
- now $78.46 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $79.49 (+1.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $74.65–$84.33
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $69.29–$89.17
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-20 | −50.9% | −50.9% | +0.0% |
| 2020-02-21 | −48.5% | −50.5% | +0.0% |
| 2020-02-19 | −46.3% | −46.3% | +1.6% |
| 3 best | |||
| 2009-07-09 | +57.2% | −0.5% | +57.2% |
| 2009-07-06 | +56.7% | −1.4% | +56.7% |
| 2009-04-08 | +55.9% | +0.0% | +55.9% |
5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | Keohane Sean D | director | Sale | 134,895 @ $85.00 | $11.5M | −25.0% of holding | not yet — horizon still open | not yet — horizon still open | 404,134 | Form 4 · filed 3 days after the trade |
| 2026-08-24 | Keohane Sean D | director | Sale | 2,779 @ $85.50 | $238K | −1.0% of holding | not yet — horizon still open | not yet — horizon still open | 288,873 | Form 4 · filed 2 days after the trade |
| 2026-08-07 | Keohane Sean D | director | Sale | 91,923 @ $86.41 | $7.9M | −18.5% of holding | −7.4% | not yet — horizon still open | 404,134 | Form 4 · filed 4 days after the trade |
| 2025-08-14 | Keohane Sean D | director | Sale | 80,304 @ $79.24 | $6.4M | −17.9% of holding | −2.6% | −9.2% | 369,195 | Form 4 · filed 1 day after the trade |
| 2025-08-14 | Keohane Sean D | director | Sale | 24,086 @ $79.25 | $1.9M | −6.2% of holding | −2.6% | −9.2% | 363,887 | Form 4 · filed 1 day after the trade |
| 2025-08-14 | Keohane Sean D | director | Sale | 7,677 @ $79.62 | $611K | −2.1% of holding | −2.6% | −9.2% | 361,518 | Form 4 · filed 1 day after the trade |
| 2025-08-14 | Keohane Sean D | director | Sale | 2,369 @ $79.63 | $189K | −0.7% of holding | −2.6% | −9.2% | 361,518 | Form 4 · filed 1 day after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
153 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | Keohane Sean D | director | Award / grant | 284 | 48,115 | Form 4 |
| 2026-09-11 | McLaughlin Erica | director | Award / grant | 61 | 10,362 | Form 4 |
| 2026-09-11 | Kalita Karen A | officer | Award / grant | 31 | 5,341 | Form 4 |
| 2026-09-11 | DELGROSSO DOUGLAS G | director | Award / grant | 31 | 5,196 | Form 4 |
| 2026-09-11 | Nathoo Raffiq | director | Award / grant | 11 | 1,889 | Form 4 |
| 2026-09-11 | Dumont Lisa M | officer | Award / grant | 4 | 747 | Form 4 |
| 2026-09-11 | Masterson William F III | officer | Award / grant | 3 | 530 | Form 4 |
| 2026-08-28 | Keohane Sean D | director | Option exercise | 134,895 | 539,029 | Form 4 |
| 2026-08-28 | Keohane Sean D | director | Option exercise | 134,895 | 0 | Form 4 |
| 2026-08-24 | Keohane Sean D | director | Option exercise | 2,779 | 291,652 | Form 4 |
| 2026-08-24 | Keohane Sean D | director | Option exercise | 2,779 | 134,895 | Form 4 |
| 2026-08-07 | Keohane Sean D | director | Option exercise | 91,923 | 496,057 | Form 4 |
| 2026-08-07 | Keohane Sean D | director | Option exercise | 91,923 | 0 | Form 4 |
| 2026-06-30 | Nathoo Raffiq | director | Award / grant | 262 | 1,878 | Form 4 |
| 2026-06-30 | Keohane Sean D | director | Award / grant | 84 | 47,831 | Form 4 |
| 2026-06-12 | Keohane Sean D | director | Award / grant | 256 | 47,747 | Form 4 |
| 2026-06-12 | McLaughlin Erica | director | Award / grant | 55 | 10,301 | Form 4 |
| 2026-06-12 | Kalita Karen A | officer | Award / grant | 28 | 5,310 | Form 4 |
| 2026-06-12 | DELGROSSO DOUGLAS G | director | Award / grant | 28 | 5,165 | Form 4 |
| 2026-06-12 | Nathoo Raffiq | director | Award / grant | 9 | 1,616 | Form 4 |
| 2026-06-12 | Dumont Lisa M | officer | Award / grant | 4 | 743 | Form 4 |
| 2026-06-12 | Masterson William F III | officer | Award / grant | 3 | 527 | Form 4 |
| 2026-03-31 | Nathoo Raffiq | director | Award / grant | 315 | 1,608 | Form 4 |
| 2026-03-13 | Keohane Sean D | director | Award / grant | 306 | 47,491 | Form 4 |
| 2026-03-13 | McLaughlin Erica | director | Award / grant | 66 | 10,246 | Form 4 |
| 2026-03-13 | Kalita Karen A | officer | Award / grant | 34 | 5,281 | Form 4 |
| 2026-03-13 | DELGROSSO DOUGLAS G | director | Award / grant | 33 | 5,137 | Form 4 |
| 2026-03-13 | Nathoo Raffiq | director | Award / grant | 8 | 1,292 | Form 4 |
| 2026-03-13 | Dumont Lisa M | officer | Award / grant | 5 | 739 | Form 4 |
| 2026-03-13 | Masterson William F III | officer | Award / grant | 3 | 524 | Form 4 |
| 2026-01-08 | Kirby William C. | director | Award / grant | 486 | 27,688 | Form 4 |
| 2026-01-08 | Vanlancker Thierry FJ | director | Award / grant | 2,298 | 4,902 | Form 4 |
| 2026-01-08 | Williams Michelle Elizabeth | director | Award / grant | 2,298 | 6,776 | Form 4 |
| 2026-01-08 | Wilson Frank Anders | director | Award / grant | 2,298 | 18,552 | Form 4 |
| 2026-01-08 | Yan Christine Y | director | Award / grant | 2,298 | 17,171 | Form 4 |
| 2026-01-08 | DELGROSSO DOUGLAS G | director | Award / grant | 2,298 | 15,079 | Form 4 |
| 2026-01-08 | Morrow Michael M | director | Award / grant | 2,298 | 22,302 | Form 4 |
| 2026-01-08 | Nathoo Raffiq | director | Award / grant | 2,298 | 9,266 | Form 4 |
| 2026-01-08 | Arnold Cynthia A | director | Award / grant | 2,298 | 19,620 | Form 4 |
| 2026-01-08 | ENRIQUEZ CABOT JUAN | director | Award / grant | 486 | 41,526 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.